Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The New England Journal of Medicine|November 25, 2017
A Controlled Trial of Erenumab for Episodic MigrainePeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.Cephalalgia : an International Journal of Headache|August 9, 2018
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumabDawn C Buse, Richard B Lipton, Yngve Hallström, et al.Cephalalgia : an International Journal of Headache|February 24, 2018
ARISE: A Phase 3 randomized trial of erenumab for episodic migraineDavid W Dodick, Messoud Ashina, Jan Lewis Brandes, et al.The Journal of Headache and Pain|July 24, 2021
Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trialsStewart J Tepper, Messoud Ashina, Uwe Reuter, et al.Neurology|July 9, 2020
One-year sustained efficacy of erenumab in episodic migraine: Results of the STRIVE studyPeter J Goadsby, Uwe Reuter, Yngve Hallström, et al.Journal of the American Academy of Dermatology|October 18, 2023
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trialJoseph F Merola, Lawrence Charles Parish, Lyn Guenther, et al.Cephalalgia : an International Journal of Headache|November 12, 2019
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensionsMessoud Ashina, David Kudrow, Uwe Reuter, et al.The Journal of Headache and Pain|October 3, 2018
Early onset of efficacy with erenumab in patients with episodic and chronic migraineTodd Schwedt, Uwe Reuter, Stewart Tepper, et al.Neurology|December 20, 2019
Vascular safety of erenumab for migraine preventionDavid Kudrow, Julio Pascual, Paul K Winner, et al.Pageof 2